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Summary
Alterations of cerebral venous drainage have been
demonstrated in chronic migraine (CM), suggest-
ing that cerebral venous hemodynamic abnormal-
ities (CVHAs) play a role in this condition.  The aim
of the present study was to look for a correlation
between CM and CVHAs.
We recruited 33 subjects suffering from CM with
or without analgesic overuse, 29 episodic
migraine (EM) patients with or without aura, and
21 healthy subjects as controls (HCs). CVHAs
were evaluated by transcranial and extracranial
echo-color Doppler evaluation of  five venous
hemodynamic parameters. 
CVHAs were significantly more frequent in the CM
and EM patients than in the HCs. In the migraine
patients, CVHAs were not correlated with clinical
features.
Cerebral venous hemodynamic abnormalities in
episodic and chronic migraine 
The significantly greater frequency of CVHAs
observed in the migraineurs may reflect a possible
relationship between migraine and these abnor-
malities. Prospective longitudinal studies are
needed to investigate whether CVHAs have a role
in the processes of  migraine chronification.
KEY WORDS: cerebral venous hemodynamic abnormalities, chron-
ic cerebrospinal venous insufficiency, chronic migraine, migraine
Introduction 
Chronic migraine (CM) is one of the most disabling pri-
mary headache forms (Lipton, 2009), whose underly-
ing processes are not yet fully elucidated. It has been
speculated that the development of CM involves pain
facilitation processes (mediated by central sensitiza-
tion mechanisms) that depend on the frequent repeti-
tion of the attacks (Schwedt, 2014).
A high frequency of headache attacks and a long his-
tory of migraine have each been correlated with the
accumulation of iron in the periaqueductal gray as well
as in the red nucleus, putamen and globus pallidus
(Welch  et al., 2001; Kruit et al., 2009, 2010).  In view
of the high iron content of these structures, it has been
hypothesized that repeated hyperoxia could cause
free radical cellular damage that might be identified by
measuring cumulative iron sequestration in brain tis-
sue (Welch, 2003; Nagesh et al., 2000). 
This ‘iron hypothesis’ might represent a mechanism
able to explain the transition of the clinical phenotype
from episodic migraine (EM) to CM (Welch, 2009).
High levels of iron in brain tissue have also been
found in other neurodegenerative and autoimmune
diseases (Zamboni et al., 2007; Singh and Zamboni,
2009). In particular, in multiple sclerosis (MS) the dep-
osition of iron has been correlated with the presence
of venous insufficiency and with cerebral congestion
(Zamboni et al., 2007; Singh and Zamboni, 2009). 
Taking into account that cerebral venous abnormali-
ties have been recently described in CM (Fofi et al.,
2012; De Simone et al., 2011), we hypothesize that
the occurrence of sterile inflammation due to frequent
migraine attacks, associated with abnormal venous
circulation, might facilitate the deposition of iron in tar-
get brain structures and then favor the processes of
migraine chronification. For this reason, we speculate
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that cerebral venous hemodynamic abnormalities
(CVHAs) could be more frequent in chronic than
episodic migraineurs. 
Materials and methods
We consecutively recruited patients attending our
headache clinic and suffering from CM with or without
analgesic overuse (codes 8.2 and 1.5.1 in the
International Classification of Headache Disorders, 2nd
Edition, ICHD-II) and EM with or without aura (ICHD-II
codes 1.2 and 1.1). A group of age- and sex-matched
healthy subjects with no personal or family history of
headache and no vascular risk factors were also
enrolled as controls (HCs). The study was approved
by the local ethics committee and all the subjects par-
ticipating in the study (cases and controls) provided
their written informed consent, in accordance with the
Declaration of Helsinki. 
The inclusion criteria were age between 18 and 65
years, and the absence of a history of vascular risk
factors such as hypertension, diabetes mellitus, obe-
sity, thrombophilia, autoimmune diseases, cardio-
cerebrovascular disease, alcohol abuse and drug
abuse. Migraine patients who were under prophylactic
migraine therapy or had suspended it less than two
months previously were also excluded.
All the subjects underwent standard clinical and neu-
rological examinations. In the migraine patients, data
on the following clinical characteristics of headache
attacks were collected: type, location, intensity of pain
(assessed by visual analog scale), frequency of
attacks (days/month), duration of attacks (in hours),
presence of aura, drug intake (number of pills per
month), and disease duration (in years). To assess the
impact of migraine on quality of life, we used two
questionnaires: the Headache Impact Test (HIT-6), in
which a score >50 indicates severe impact, and the
Migraine Disability Assessment Scale (MIDAS), in
which a score >20 indicates severe disability. All the
patients underwent brain magnetic resonance imaging
(MRI), including arterial and venous MR angiography. 
CVHAs were assessed, according to strict operational
criteria, by a single expert ultrasonographer (FP), who
was blind to the identity of the sample examined. The
subjects were evaluated by transcranial and extracra-
nial echo-color Doppler (ECD) examination (Zanie -
wski et al., 2013). The apparatus used was a Siemens
Acuson Sequoia 4v1c transducer with a 2 MHz probe
for the study of the deep cerebral veins  (DCVs) and a
9I4 9 MHz probe for studying the extracranial venous
circulation. The patient was placed on a tilt bed so that
the extracranial ECD, serving to investigate the inter-
nal jugular veins (IJVs) and vertebral veins (VVs),
could be combined with the intracranial ECD, per-
formed to study the DCVs. The procedure started with
the patient in supine position, while the subsequent
phase of the examination was conducted in a sitting
position after an adaptation time. Episodic
migraineurs underwent the examination during the
interictal phase (at least 72 hours after the last attack).
In patients with CM, the recordings were made regard-
less of the attack stage. 
The five intracranial and extracranial venous hemody-
namic parameters of the Venous Hemodynamic
Insufficiency Severity Score (VHISS) (Zamboni et al.,
2007) were evaluated: 
VH1) Reflux/bidirectional flow in the IJVs and/or in the
VVs, in sitting and in supine positions, defined as flow
directed towards the brain for a duration of >0.88 sec-
onds; 
VH2) Reflux/bidirectional flow in the DCVs, defined as
reverse flow for a duration of 0.5 seconds in one of the
intracranial veins; 
VH3) B-mode abnormalities indicating stenosis in
IJVs. IJV stenosis is defined as an IJV cross-section-
al area (CSA) ≤0.3 cm2;
VH4) Flow that is not Doppler-detectable in the IJVs
and/or VVs despite multiple deep breaths; 
VH5) Reverted postural control of the main cerebral
venous outflow pathway verified by measuring the dif-
ference between the IJV CSA in the supine and
upright positions. 
Positivity of any one of the five parameters described
above was taken as an indication of the presence of
CVHAs. In addition, the data were also analyzed
according to the criteria proposed by Zamboni et al.
(2007) to define the presence of chronic cerebrospinal
venous insufficiency (CCSVI). According to these cri-
teria, CCSVI is present when at least two of the five
venous hemodynamic parameters listed above are
altered.
Outcome measures and statistical analysis
Clinical migraine data and the presence of CVHAs
were the main outcome measures in the three groups
(CM, EM, HCs). Within the CM and EM groups, we
analyzed patients separately according to the duration
of their migraine history (more than 10 years versus
less than 10 years) in order to explore the hypothesis
that the effect of CVHAs might be greater in those with
a longer disease history.
All the parameters were checked for normal distribu-
tion using the Wilks-Shapiro test. As the variables in
the three groups did not all fit a normal distribution, the
between-group comparisons were tested with non-
parametric tests. The Mann-Whitney test was used for
continuous variables and Fisher’s exact test for dis-
crete variables. Statistical significance was set at <0.05
after Bonferroni correction. 
To study whether the presence of CHVAs might influ-
ence the clinical burden in CM and EM patients, a
multivariate analysis of variance (MANOVA) was car-
ried out to predict the severity of migraine disease. We
used all the migraine parameters (frequency, intensity,
attack duration in hours, etc.) as dependent factors in
a pooled analysis, while group (episodic vs chronic),
disease duration in years and presence of CCSVI
were used as independent factors. Age and gender
were used as covariants in the analysis. 
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Given the lack of epidemiological data on both CCSVI
and CHVAs in healthy subjects and migraine patients,
we performed a post-hoc power analysis to detect the
B power of our study with a significance level of 0.05.
The results of this analysis are described in the follow-
ing section. All statistical analyses were performed
using SPSS, version 17.
Results 
We recruited 33 patients with CM, with or without anal-
gesic overuse, 29 patients with EM, with or without
aura, and 21 HCs. The patient groups did not differ
significantly in demographic characteristics (Table I).
Compared with the EM patients, the CM group had
significantly higher values for attack frequency and
duration, and intake of pills; they also had significant-
ly higher MIDAS and HIT-6 scores. The intensity of
pain and the presence of aura did not differ between
the CM and EM groups.
Table II summarizes the distribution of the parameters
indicating the presence of CVHAs.
Compared with the controls, the CM and EM patients
showed a higher frequency of positive VH1, VH3 and
VH4 parameters (in the case of VH3, only the compar-
ison with the EM patients was significant) (Table III).
Furthermore, comparison of the venous hemodynam-
ic parameters between the CM and EM patients
revealed a significantly higher presence of VH4 in the
CM group. After Bonferroni correction, only the differ-
ences in VH4 remained significant between the three
groups (Table III).
CCSVI was present in 30.3% (n = 10) of the CM and 24%
(n = 7) of the EM patients, whereas it was not observed
in the HCs (Table III). The presence of CCSVI was sig-
nificantly higher in the CM vs EM (p=0.04) and EM vs HC
groups  (p=0.04), after Bonferroni correction. There was
no difference between the CM group  and the HCs. 
We observed that neither the presence of a positive
VH4 criterion nor the presence of CCSVI affected the
characteristics of the headache in the EM and CM
groups. In fact, there were no differences in features
such as attack frequency, duration of attacks, intensi-
ty of pain, and number of pills per month, or in HIT-6
and MIDAS scores. These results were also confirmed
Cerebral venous hemodynamic abnormalities and migraine
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Table I - Demographic, clinical and neuroradiological characteristics.
CM (n=33) EM (n=29) HCs (n=21)
Sex (female) 82% 72.4% 71.4%
Age (years) 40.5 ± 12.3 34.4 ± 10.4 33.2 ± 4.3
MOH 75.5% - -
Number of analgesics/month 19.3* ± 9.6 4.4 ± 2.9 -
Attack frequency (days/month) 22.7* ± 6.5 4.5 ± 3.2 -
Attack duration (hours/attack) 38.5* ± 21.5 29.4 ± 22.9 -
Intensity of pain (VAS) 8.8 ± 1 8 ± 1.4 -
Aura 24% 24% -
Years of migraine 20.5 ± 10.7 17.2 ± 9.7 -
Years with CM 6.7 ± 8.5 - -
HIT-6 score 63.6*± 9 57.8 ± 8.5 -
MIDAS score 71* ± 50 13.2 ± 13.4 -
MRI 5/33 gliotic foci 3/29 gliotic foci -
2/33 hypoplasia of the 1/29 hypoplasia of the transverse 
transverse venous sinuses and sigmoid venous sinuses
Abbreviations: CM=chronic migraine; EM=episodic migraine; HCs=healthy controls; MOH=medication overuse headache; VAS=visual analog scale; 
HIT-6=Headache Impact Test; MIDAS=Migraine Disability Assessment Scale; MRI=magnetic resonance imaging; *significant value (p<0.05)
Table II - Distribution of neurosonological venous hemodynamic criteria (VH1-VH5) in the sample populations.
VH1 VH2 VH3 VH4 VH5
CM (n=33) 30.3% - 63.6% 27.2% -
EM (n=29) 20.6% - 75.8% 6.8% -
HCs (n=21) - - 31% - -
Abbreviations: CM=chronic migraine; EM=episodic migraine; HCs=healthy controls
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by the application of the MANOVA model, which
showed that neither a longer disease duration nor the
presence of CCSVI was significantly associated with a
worse clinical outcome (Wilks lambda, Pillai-Bartlett
trace and Lawley-Hotelling trace: p>0.05; Roy’s great-
est root: p<0.05).
Finally, in the patients with a longer-than-10-year
migraine disease history, we observed that both the
EM and the CM patients had a positive VH4 parame-
ter.
With regard to migraine disease duration, the pres-
ence of CCSVI was more frequent in CM patients with
a long as opposed to a short disease duration (53% vs
6%). On the contrary, CCSVI was less frequent in EM
patients with a long disease duration than in those
with a short one (12% vs 29%) (Table IV). 
The post-hoc power analysis for the Chi-square test
showed a B-power of 0.81, with alpha=0.05, degree of
freedom=5, number of patients=83 (CM+EM+HCs),
effect size=0.4 (post-hoc).
Discussion 
The processes underlying CM are still debated.
However, a mechanism of central sensitization to
painful stimuli (a multi-step mechanism, probably
involving sterile neuroinflammation, impairment of
endogenous analgesia and persistent cortical hyper-
excitability) seems to play a main role in the transition
from the episodic to the chronic form. Welch (2003)
suggested that iron deposition in selective subcortical
structures, observed in migraineurs, might be a con-
sequence of sterile neuroinflammation and a possible
marker of a proinflammatory state. 
From this perspective, it has been claimed that cere-
bral venous reflux could act as a proinflammatory
stimulus and promote iron deposition in chronic
inflammatory diseases (such as MS) and other neu-
rodegenerative diseases  (Zamboni, 2006; Zamboni et
al., 2007; Singh and Zamboni, 2009; Adams,1988;
Zivadinov et al., 2011). 
The origin of CVHAs has not yet been determined. It
has been suggested that they may be physiological
(Doepp et al., 2008; Baracchini et al., 2011), aging-
dependent (Chung et al., 2010, 2011), congenital (Lee
et al., 2010), or pathological.
Taking into account that cerebral venous abnormali-
ties have recently been described in CM (Fofi et al.,
2012; De Simone et al., 2011), we hypothesized that
the occurrence of sterile inflammation due to frequent
migraine attacks, associated with abnormal venous
circulation, might facilitate the deposition of iron in tar-
get brain structures and then favor the processes of
migraine chronification. We therefore investigated
CVHAs in both chronic and episodic migraineurs.
CHVAs and migraine
We found that CVHAs were significantly more fre-
quent both in chronic and in episodic migraineurs
compared with HCs. In particular, the presence of a
positive VH4 parameter was found to be significantly
more frequent in the migraineurs overall than in the
controls, and also in the chronic compared with the
episodic form of migraine.  Classifying CVHAs accord-
ing to the criteria of Zamboni et al. (2007), we
observed a significant occurrence of CCSVI in both
the EM (24%) and the CM (30.3%) patients, whereas
it was not found in any of the HCs. 
Data on the prevalence of CCSVI in MS are inconclu-
sive and widely varying, ranging from 0 to 100%, and
some concerns have been raised about the repro-
ducibility of the VHISS criteria (Baracchini et al.,
2012). However our data seem quite consistent with
the findings of a recent large Italian multicenter study
in MS patients and controls (the CoSMo study), which
demonstrated the presence of CCSVI in about 2% of
B. Petolicchio et al.
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Table III - Between-group comparisons of single neurosonological venous hemodynamic criteria (VH1-VH5)  and presence
of CCSVI. 
VH1 VH3 VH4 CCSVI
CM vs EM 30.3% vs 20.6%; p=0.56 63.6% vs 75.8%; p=0.8 27.2% vs 6.8%; p=0.003* 30.3%; p=0.04*
EM vs HCs 20.6% vs 0%; p=0.06 75.8% vs 31%; p=0.05 6.8% vs 0%; p=0.024* 24%; p=0.04*
CM vs HCs 30.3% vs 0%; p=0.08 63.6% vs 31%; p=0.32 27.2% vs 0%; p=0.003* -
Abbreviations: CM=chronic migraine; EM=episodic migraine; HCs=healthy controls; CCSVI=chronic cerebrospinal venous insufficiency; *significant after
Bonferroni correction
Table IV - CCSVI and disease duration in chronic migraine and episodic migraine groups (Fisher’s exact test 0.034).
Patients with CCSVI (n=17) <10 years >10 years
CM (n=10) 6% (n=1) 53% (n=9)
EM (n=7) 29% (n=5) 12% (n=2)
Abbreviations: CM=chronic migraine; EM=episodic migraine; CCSVI=chronic cerebrospinal venous insufficiency
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HCs (Comi et al., 2013). These data are also similar to
results obtained with catheter venography (still the
gold standard for the diagnosis of venous flow disor-
ders) in a healthy population (Traboulsee  et al.,
2014).
One possible explanation for the consistency, with lit-
erature data, of our results on CVHAs in controls is
that our subjects were evaluated by a single trained
expert, thus reducing inter-operator variability. 
In addition, in our patients, MRI examination did not
reveal major morphological abnormalities of the cere-
bral venous circulation. This suggests that the signifi-
cant increase in CVHAs observed in the migraineurs
may reflect a possible relationship between migraine
and abnormalities in cerebral venous hemodynamics.
CVHAs and migraine chronification
Hemodynamic abnormalities in the brain that affect
both the arterial and the venous system have already
been demonstrated in migraineurs (Fofi et al., 2012;
De Simone et al., 2010).  Abnormalities of venous
drainage, both morphological and/or functional, could
result in a modification of the cerebral venous pres-
sure. It has been hypothesized that mild but persistent
central venous hypertension could facilitate pain
hypersensitivity and induce central sensitization.
Central venous hypertension might, due to conges-
tion, cause a relative dilatation of the large vessels,
which might promote inappropriate continuous noci-
ceptive firing. This, in turn, would lead to a progressive
increase in the frequency of migraine attacks, thus
facilitating the progression towards migraine chronici-
ty (De Simone et al., 2010).
The relationship between cerebral venous abnormali-
ties and migraine clinical features is still under inves-
tigation. In our study, no differences in clinical param-
eters, clinical scales or the presence of CVHAs or
CCSVI were found between the EM and CM groups.
Similarly, the multivariate model performed to calcu-
late the burden of migraine disease showed a signifi-
cant value only in the Roy’s greatest root, with the
other three multivariate measures giving non-signifi-
cant values. Since the Roy’s greatest root represents
only the upper boundary of the F distribution, it has a
higher probability of Type I error, leading to the rejec-
tion of a true null hypothesis. Thus it is generally dis-
regarded when the other tests are not significant.
Garaci et al. (2012) confirmed that there is no signifi-
cant clinical relationship between MS and CCSVI,
nevertheless the presence of CCSVI in MS patients as
well as in healthy subjects was found to be correlated
with decreased cerebral blood flow and cerebral blood
volume.
This discrepancy could be explained, in part, by a new
report on the presence of a lymphatic system in the
brain. Louveau et al. (2015) recently discovered func-
tional lymphatic vessels lining the dural sinuses, and
suggested that a malfunction of this system could
have a role in a variety of neuroinflammatory and neu-
rodegenerative diseases.
Our initial hypothesis was that CVHAs could facilitate
cerebral inflammatory processes, and, by supporting
the phenomena of central sensitization, lead to the
chronification of migraine. Unexpectedly, we did not
find differences in the prevalence of CVHAs between
the EM and CM groups. Therefore, our data suggest
that CVHAs could play a role in the pathophysiology of
migraine in the broad sense. In this regard, it should
be said that migraine is a multifactorial disease and
therefore it cannot be excluded that the presence of
CVHAs may play a specific role in at least a subgroup
of patients with migraine.
CVHAs and migraine disease duration
In an interesting study in patients with MS, Yamout et
al. (2010) observed that the presence of extracranial
venous abnormalities was significantly higher in
patients with a long disease duration (over 10 years).
They speculated that these abnormalities were a late
phenomenon linked, precisely, to the long duration of
the disease. The authors stated that, in MS in particu-
lar, chronic perivenous inflammation could hypotheti-
cally lead to the release of several inflammatory medi-
ators; this would provoke venous endothelium alter-
ations or vein valvulitis, which in turn can lead to
venous stenosis.
In our study, we observed a higher prevalence of
CVHAs in patients with CM and a more-than-10-year
history of migraine disease. In patients with EM, the
pattern was reversed: CVHAs were more frequent in
cases with a migraine disease duration shorter than
10 years. This finding suggests that the presence of
CVHAs in migraine patients may be a predisposing
factor for migraine chronification. In patients with an
EM history longer than 10 years, it is reasonable to
find a lower occurrence of CVHAs. 
Conclusion
In conclusion, our data showed a higher prevalence of
CVHAs in migraineurs without any correlation with the
clinical characteristics or type of migraine (i.e. episod-
ic or chronic). Longitudinal studies in patients with EM
could be useful to clarify whether CVHAs can play a
role in facilitating the processes of migraine chronifi-
cation.
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